Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
NAPP2, a peroxisomal membrane protein, is also a transcriptional corepressor.
Gavva NR, Wen SC, Daftari P, Moniwa M, Yang WM, Yang-Feng LP, Seto E, Davie JR, Shen CK. Gavva NR, et al. Genomics. 2002 Mar;79(3):423-31. doi: 10.1006/geno.2002.6714. Genomics. 2002. PMID: 11863372
Human ITCH is a coregulator of the hematopoietic transcription factor NF-E2.
Chen X, Wen S, Fukuda MN, Gavva NR, Hsu D, Akama TO, Yang-Feng T, Shen CK. Chen X, et al. Genomics. 2001 Apr 15;73(2):238-41. doi: 10.1006/geno.2001.6512. Genomics. 2001. PMID: 11318614
Loading of DNA-binding factors to an erythroid enhancer.
Wen SC, Roder K, Hu KY, Rombel I, Gavva NR, Daftari P, Kuo YY, Wang C, Shen CK. Wen SC, et al. Mol Cell Biol. 2000 Mar;20(6):1993-2003. doi: 10.1128/mcb.20.6.1993-2003.2000. Mol Cell Biol. 2000. PMID: 10688646 Free PMC article.
Derepression of human embryonic zeta-globin promoter by a locus-control region sequence.
Huang BL, Fan-Chiang IR, Wen SC, Koo HC, Kao WY, Gavva NR, Shen CK. Huang BL, et al. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14669-74. doi: 10.1073/pnas.95.25.14669. Proc Natl Acad Sci U S A. 1998. PMID: 9843947 Free PMC article.
Molecular determinants of vanilloid sensitivity in TRPV1.
Gavva NR, Klionsky L, Qu Y, Shi L, Tamir R, Edenson S, Zhang TJ, Viswanadhan VN, Toth A, Pearce LV, Vanderah TW, Porreca F, Blumberg PM, Lile J, Sun Y, Wild K, Louis JC, Treanor JJ. Gavva NR, et al. J Biol Chem. 2004 May 7;279(19):20283-95. doi: 10.1074/jbc.M312577200. Epub 2004 Mar 2. J Biol Chem. 2004. PMID: 14996838
TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: Compounds' pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development.
Garami A, Pakai E, McDonald HA, Reilly RM, Gomtsyan A, Corrigan JJ, Pinter E, Zhu DXD, Lehto SG, Gavva NR, Kym PR, Romanovsky AA. Garami A, et al. Among authors: gavva nr. Acta Physiol (Oxf). 2018 Jul;223(3):e13038. doi: 10.1111/apha.13038. Epub 2018 Feb 16. Acta Physiol (Oxf). 2018. PMID: 29352512 Free PMC article.
Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides.
Doherty EM, Fotsch C, Bo Y, Chakrabarti PP, Chen N, Gavva N, Han N, Kelly MG, Kincaid J, Klionsky L, Liu Q, Ognyanov VI, Tamir R, Wang X, Zhu J, Norman MH, Treanor JJ. Doherty EM, et al. J Med Chem. 2005 Jan 13;48(1):71-90. doi: 10.1021/jm049485i. J Med Chem. 2005. PMID: 15634002
Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists.
Tamayo N, Liao H, Stec MM, Wang X, Chakrabarti P, Retz D, Doherty EM, Surapaneni S, Tamir R, Bannon AW, Gavva NR, Norman MH. Tamayo N, et al. J Med Chem. 2008 May 8;51(9):2744-57. doi: 10.1021/jm7014638. Epub 2008 Apr 3. J Med Chem. 2008. PMID: 18386885
50 results
Jump to page
Feedback